UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
___________________________________________________________________
Date of Report (Date of earliest event reported): October 14, 2009
ANTIVIRAL TECHNOLOGIES, INC.
| Nevada |
| 000-53449 |
| 26-1188469 | |
| (State or other jurisdiction of incorporation) |
| (Commission File Number) |
| (IRS Employer Identification No.) | |
|
|
|
|
| ||
(Exact Name of Registrant as Specified in Charter)
4807 S. Zang Way Morrison, Co 80465 |
(Address of principal executive offices) |
Registrant’s telephone number, including area code: 011-852- 2159-7863
Table Mesa Acquisitions, Inc.
(Former name)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 DFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR
On October 8, 2009, the Registrant caused a corporation to be formed under the laws of the State of Nevada under the name Antiviral Technologies, Inc., (“Merger Sub”), as a wholly-owned subsidiary of the Registrant.
On October 13, 2009, the Registrant caused to be filed with the Nevada Secretary of State Articles of Merger and an Agreement and Plan of Merger, copies of which are attached hereto as Exhibit 3.1 and hereby incorporated by reference, whereby Merger Sub merged with and into the Registrant with the Registrant remaining as the surviving entity. The effective date of the merger was October 13, 2009. As a result of the merger, the separate existence of Merger Sub ceased and the corporate name of the Registrant was changed from “Table Mesa Acquisitions, Inc.” to “Antiviral Technologies, Inc.” Prior to the merger, Merger Sub had no liabilities and nominal assets. The Registrant was the surviving corporation in the merger and, except for the name change provided for in the Agreement and Plan of Merger, there is no change in the directors, officers, capital structure or business of the Re gistrant.
Pursuant to Nevada Revised Statute, Section 92A.180, the Registrant, as the parent domestic corporation owning at least 90 percent of the outstanding shares of common stock of the Merger Sub, may merge Merger Sub into itself without the approval of the Registrant’s shareholders, and may also effectuate a name change in conjunction with the merger without the approval of the Registrant’s shareholders.
9.01. FINANCIAL STATEMENTS, AND EXHIBITS.
(d)
Exhibit 3.1 Articles of Merger with Agreement and Plan of Merger by and between Table Mesa Acquisitions, Inc. and Antiviral Technologies, Inc.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ANTIVIRAL TECHNOLOGIES, INC.
Date: October 14, 2009
/s/ Jay Lutsky
---------------------------------
By: Jay Lutsky
Its: Chief Executive Officer
